Drug Database
Back to search

Poland· PL-100380040

Emtricitabine/Tenofovir disoproxil Krka

A tenofovir disoproxil and emtricitabine product containing emtricitabinum + tenofovirum disoproxilum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEmtricitabine/Tenofovir disoproxil Kr…ATCJ05AR03REGISTER NO.PL-100380040PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about emtricitabinum + tenofovirum disoproxilumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil and emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR03 (tenofovir disoproxil and emtricitabine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search tenofovir disoproxil and emtricitabine products by name

Tenofovir disoproxil and emtricitabine · ATC J05AR03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Emtricitabinum + Tenofovirum disoproxilum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
J05AR03
ATC class
Tenofovir disoproxil and emtricitabine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991305796
  • gtin
    05909991305802
  • gtin
    05909991305819
  • gtin
    05909991305826

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for tenofovir disoproxil and emtricitabine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tenofovir disoproxil and emtricitabine against other medicinesHow interaction checks work

Tenofovir disoproxil and emtricitabine · interactions on record

9 records

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tenofovir disoproxil and emtricitabine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil and emtricitabine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Emtricitabin/Tenofovir Sandoz, Emtricitabin/Tenofovirdisoproxil Stada
  • Belgium · Emtricitabin/Tenofovir Disoproxil Ab
  • Cyprus · Exatron
  • Germany · Emtenovo, Emtricitabin Tenofovirdisoproxil Zentiva
  • Denmark · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/Tenofovir Disoproxil "sandoz"
  • Estonia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
  • Spain · Emtricitabina/Tenofovir Disoproxilo Aurovitas, Emtricitabina/Tenofovir Disoproxilo Glenmark
  • Finland · Emtricitabine / Tenofovir Disoproxil Stada, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • France · Emtricitabine/ Tenofovir Disoproxil Sandoz, Emtricitabine/Tenofovir Disoproxil Accord
  • United Kingdom (Northern Ireland) · Emtricitabin/Tenofovirdisoproxil Amarox, Emtricitabine/ Tenofovir Disoproxil
  • Greece · Argiodin, Emtricitabin/Tenofovir Disoproxil Accord
  • Croatia · Emtricitabin/Tenofovirdizoproksil Pliva
  • Hungary · Dunotrisin, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • Ireland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Clonmel
  • Iceland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Krka
  • Italy · Emtricitabina E Tenofovir Disoproxil Aequilibrium Pharma, Emtricitabina E Tenofovir Disoproxil Aurobindo
  • Liechtenstein · Emtricitabine/Tenofovir Disoproxil Mylan, Emtricitabine/Tenofovir Disoproxil Zentiva
  • Lithuania · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
  • Latvia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Teva
  • Netherlands · Emtricitabine Tenofovir Disoproxyl Fumarate Aurobindo, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • Norway · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/ Tenofovir Disoproxil Cipla
  • Portugal · Emtricitabina + Tenofovir Accord, Emtricitabina + Tenofovir Disoproxil
  • Romania · Emtricitabină/Tenofovir Disoproxil Stada, Emtricitabină/Tenofovir Disoproxil Teva
  • Sweden · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Glenmark
  • Slovenia · Emtricitabin/Dizoproksiltenofovirat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee6b40e3-6629-401c-adce-5ba66d4f4acf
GET /v1/drugs/ee6b40e3-6629-401c-adce-5ba66d4f4acf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "200 mg + 245 mg",
  "packaging": "05909991305796 ¦ Rpz ¦ EU/1/16/1151/001 ¦ 119056\n28 tabl.\n05909991305802 ¦ Rpz ¦ EU/1/16/1151/002 ¦ 119057\n30 tabl.\n05909991305819 ¦ Rpz ¦ EU/1/16/1151/003 ¦ 119058\n84 tabl.\n05909991305826 ¦ Rpz ¦ EU/1/16/1151/004 ¦ 119059\n90 tabl.\nRpz ¦ EU/1/16/1151/005 ¦ 152323\n28 tabl. 28 x 1 tabletka (dawka pojedyncza)",
  "substance": "Emtricitabinum 200 mg + Tenofovirum disoproxilum 245 mg",
  "common_name": "Emtricitabinum + Tenofovirum disoproxilum",
  "pl_product_id": "100380040",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about tenofovir disoproxil and emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console